FIELD: medicine.
SUBSTANCE: proposed group of inventions relates to the field of medicine, in particular to molecular genetic diagnostics. A method and analytical system for the diagnosis of lung cancer are proposed, including primers and TaqMan probes for sequences of 7 combinations of 10 micro-RNAs: miR-107/miR-222-3p, miR-19b-3p/miR-484, miR-150-5p/miR-144-5p, miR-484/miR-374a-5p, miR-484/miR-324-5p, miR-22-5p/miR-324-5p, miR-374a-5p/miR-133b.
EFFECT: proposed group of inventions provides development of a method for the differential diagnosis of malignant lung tumors with 100% sensitivity, specificity and accuracy.
3 cl, 8 tbl, 30 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS FOR PATHOLOGICAL CHANGES DETECTION IN ORGAN OR SYSTEM OF ORGANS | 2012 |
|
RU2626540C2 |
| ONCOLYTIC VIRAL VECTORS AND THEIR APPLICATION | 2018 |
|
RU2771110C2 |
| REAGENT KIT FOR DETECTING SMALL RIBONUCLEIC ACIDS (microRNA) IN DIAGNOSING MULTIPLE MYELOMA | 2024 |
|
RU2836054C1 |
| METHOD FOR MINIMALLY INVASIVE DIAGNOSIS OF GLIOBLASTOMAS | 2022 |
|
RU2788815C1 |
| DRUG FOR TREATMENT OF TISSUE FIBROSIS BASED ON COMPONENTS OF SECRETOME OF MESENCHYMAL STROMAL CELLS, METHOD FOR OBTAINING AND APPLYING REMEDY | 2020 |
|
RU2766707C1 |
| RECOMBINANT PLASMID DNA CODING microRNA hsa-miR-145-3p, AND ITS USE AS POSITIVE CONTROL IN REAL-TIME PCR FOR DIAGNOSING CARDIOVASCULAR DISEASES AND DETECTING RISK OF THEIR DEVELOPMENT | 2025 |
|
RU2837873C1 |
| VERSIONS OF RECOMBINANT AAV AND USE THEREOF | 2015 |
|
RU2738421C2 |
| RECOMBINANT PLASMID DNA CODING microRNA hsa-miR-143-5p, AND ITS USE AS POSITIVE CONTROL IN REAL-TIME PCR FOR DIAGNOSING CARDIOVASCULAR DISEASES AND DETECTING RISK OF THEIR DEVELOPMENT | 2025 |
|
RU2837872C1 |
| METHOD FOR MINIMALLY INVASIVE DIAGNOSIS OF MENINGIOMAS AND GLIAL TUMORS WITH SPECIFICATION OF THE DEGREE OF MALIGNANCY | 2022 |
|
RU2788814C1 |
| RECOMBINANT PLASMID DNA CODING microRNA hsa-miR-143-3p, AND ITS USE AS POSITIVE CONTROL IN REAL-TIME PCR FOR DIAGNOSING CARDIOVASCULAR DISEASES AND DETECTING RISK OF THEIR DEVELOPMENT | 2025 |
|
RU2837882C1 |
